 |
 |
Below is the Ocyt 2010 issue of PDtrials.org Newsletter.There is an interesting articlde, about why new phase II CERE`120 gene therapy trials are underway, in spite of earlier phase II trials being called a "failure" see below un der: "Promising Developments in Gene Transfer Drug, CERE-120, Stem from Initially Disappointing Results" or at http://www.pdtrials.org/en/clinical_research_news/release/pr_1288114583 Questions can be directed to David Bloomquist National Programs Coordinator Parkinson's Disease Foundation (PDF) 1359 Broadway, Suite 1509 New York, NY 10018 Tel: (212) 923-4700 | (800) 457-6676 www.pdf.org October 2010 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ Parkinson's Clinical Research Newsletter www.PDtrials.org ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ Promising Developments in Gene Transfer Drug, CERE-120, Stem from Initially Disappointing Results by Raymond Bartus, Ph.D., and Joao Siffert, M.D. Although a study of gene transfer drug CERE-120, developed by Ceregene Inc., found only modest results in improving Parkinson's disease (PD) symptoms, researchers discovered insights that could breathe new life into the study therapy. http://www.pdtrials.org/en/clinical_research_news/release/pr_1288114583 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ New Clinical Trials Study of Preladenant in People with Moderate to Severe Parkinson's Disease This study will test how effective an investigational medication, Preladenant, might be in treating certain side effects caused by levodopa treatment. http://www.pdtrials.org/en/browse/all/view/300 Study of Preladenant in People with Early Parkinson's Disease This study will test the safety and effectiveness of an investigational medication, Preladenant, on the symptoms of PD. http://www.pdtrials.org/en/browse/all/view/301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ Join the National AWARE for All Webcast on Nov. 6 Is clinical research participation right for you? Come and find out at AWARE for All, a clinical research information webcast put on by the Center for Information and Study on Clinical Research. Peggy Willocks, a person with PD who advocates for clinical research participation, will discuss her experience and views on getting involved in clinical trials. The webinar will be held from 12 PM EST through 2 PM EST on Saturday, Nov. 6. There are two ways to join the webcast: find a site near you and attend a live program showing the webcast or watch the webcast from your own computer. http://www.pdtrials.org/en/clinical_research_news/release/pr_1288125577 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ Have You Participated in a Parkinson's Clinical Study? Join the Partners in Progress Honor Roll Today! If you have participated in a Parkinson's clinical study, we'd like to recognize your very personal commitment to help move Parkinson's clinical research forward by providing you with a PDtrials baseball cap as a token of our thanks and adding you to our Partners in Progress Honor Roll. Take a look at our Honor Roll of participants here [http://r20.rs6.net/tn.jsp?llr=zle7tnbab&t=b955waeab.0.0.zle7tnbab.0&id=preview&ts=S0546&p=http%3A%2F%2Fwww.pdtrials.org%2Fen%2Fpartners_in_progress], and if you would like to be included, contact us [mailto:[log in to unmask]] today! ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ Thank you for signing up to receive the PDtrials Parkinson's Clinical Research Newsletter. This newsletter provides you with information on Parkinson's disease (PD) clinical trials that are actively looking for participants, as well as news on Parkinson's research and treatments. ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ Find us on Facebook http://www.facebook.com/pages/PDtrials/67722674992 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ PDtrials is led by Parkinson's Disease Foundation [http://r20.rs6.net/tn.jsp?llr=zle7tnbab&t=b955waeab.0.0.zle7tnbab.0&id=preview&ts=S0546&p=http%3A%2F%2Fwww.pdf.org%2F] In collaboration with: APDA [http://r20.rs6.net/tn.jsp?llr=zle7tnbab&t=b955waeab.0.0.zle7tnbab.0&id=preview&ts=S0546&p=http%3A%2F%2Fwww.apdaparkinson.org%2FuserND%2Findex.asp] FOX [http://r20.rs6.net/tn.jsp?llr=zle7tnbab&t=b955waeab.0.0.zle7tnbab.0&id=preview&ts=S0546&p=http%3A%2F%2Fwww.michaeljfox.org%2F] National Parkinson Foundation [http://r20.rs6.net/tn.jsp?llr=zle7tnbab&t=b955waeab.0.0.zle7tnbab.0&id=preview&ts=S0546&p=http%3A%2F%2Fwww.parkinson.org%2Fsite%2Fpp.asp%3Fc%3D9dJFJLPwB%26b%3D71117] Parkinson's Action Network [http://r20.rs6.net/tn.jsp?llr=zle7tnbab&t=b955waeab.0.0.zle7tnbab.0&id=preview&ts=S0546&p=http%3A%2F%2Fwww.parkinsonsaction.org%2F] PA Logo New [http://r20.rs6.net/tn.jsp?llr=zle7tnbab&t=b955waeab.0.0.zle7tnbab.0&id=preview&ts=S0546&p=http%3A%2F%2Fwww.parkinsonalliance.org%2F] We Move [http://r20.rs6.net/tn.jsp?llr=zle7tnbab&t=b955waeab.0.0.zle7tnbab.0&id=preview&ts=S0546&p=http%3A%2F%2Fwww.wemove.org%2F] PDtrials is advised by: National Institutes Of Health [http://r20.rs6.net/tn.jsp?llr=zle7tnbab&t=b955waeab.0.0.zle7tnbab.0&id=preview&ts=S0546&p=http%3A%2F%2Fwww.nih.gov%2F] The Parkinson's Institute [http://r20.rs6.net/tn.jsp?llr=zle7tnbab&t=b955waeab.0.0.zle7tnbab.0&id=preview&ts=S0546&p=http%3A%2F%2Fwww.thepi.org%2Fsite%2Fparkinson] Parkinson Pipeline Project [http://r20.rs6.net/tn.jsp?llr=zle7tnbab&t=b955waeab.0.0.zle7tnbab.0&id=preview&ts=S0546&p=http%3A%2F%2Fwww.pdpipeline.org%2F] ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ © 2010 PDtrials. All Rights Reserved. ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn